Company intelligence / Profile preview

AudioCardio

Santa Monica, California, United States

Ownership: Private
Employees: ~10
Development stage: Other

Overview

AudioCardio is a digital health company focused on providing non-invasive solutions for hearing loss and tinnitus. The company's core technology, Threshold Sound Conditioning (TSC), is a clinically proven data-driven sound therapy designed to stimulate and strengthen the auditory system. By delivering personalized sound frequencies at sub-threshold levels, AudioCardio aims to improve hearing sensitivity and provide relief for individuals suffering from tinnitus. The solution is delivered via a mobile application, making it an accessible and cost-effective alternative to traditional hearing aids and clinical treatments.

Therapeutic areas: Neurology
Modalities: DeviceNon-pharmacological therapyDigital Therapeutics
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on AudioCardio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AudioCardio.

Explore the full profile